• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名肢端发育不全患者的内分泌学及表型评估

Endocrinological and phenotype evaluation in a patient with acrodysostosis.

作者信息

Ueyama Kaoru, Namba Noriyuki, Kitaoka Taichi, Yamamoto Keiko, Fujiwara Makoto, Ohata Yasuhisa, Kubota Takuo, Ozono Keiichi

机构信息

Department of Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan.

Department of Pediatrics, Osaka Hospital, Japan Community Healthcare Organization (JCHO), Osaka, Japan.

出版信息

Clin Pediatr Endocrinol. 2017;26(3):177-182. doi: 10.1297/cpe.26.177. Epub 2017 Jul 27.

DOI:10.1297/cpe.26.177
PMID:28804209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5537214/
Abstract

Acrodysostosis is characterized by distinctive facial features and severe brachydactyly. Mutations in or are known to be responsible for this disease. Cases of hormonal resistance have been reported, particularly in patients with mutations. The physical characteristics and endocrine function of pseudohypoparathyroidism type Ia is known to resemble acrodysostosis. We report the case of a 4-yr-old patient with a mutation. He had characteristic facies with an upturned nose and cone-shaped epiphyses of most phalanges. These findings have not been reported as extensive for cases of pseudohypoparathyroidism type Ia. He also had TSH resistance from birth. We performed endocrinological stimulation tests to further evaluate his endocrine status. These examinations revealed resistance to TSH and PTH, but there was normal secretion of ACTH, GH, and cortisol. An Ellsworth-Howard test resulted in normal urinary cAMP excretion. This response differs from that of pseudohypoparathyroidism type Ia. In summary, the constellation of an upturned nose, cone-shaped epiphyses of most if not all phalanges, and PTH resistance with a normal urinary cAMP response may satisfactorily enable clinical diagnosis of acrodysostosis.

摘要

肢端发育不全以独特的面部特征和严重的短指畸形为特征。已知 或 的突变是导致这种疾病的原因。已有激素抵抗病例的报道,特别是在有 突变的患者中。Ia型假性甲状旁腺功能减退症的身体特征和内分泌功能已知与肢端发育不全相似。我们报告了一例携带 突变的4岁患者。他具有特征性面容,鼻子上翘,大多数指骨的骨骺呈锥形。这些发现对于Ia型假性甲状旁腺功能减退症病例来说尚未被广泛报道。他从出生起就存在促甲状腺激素抵抗。我们进行了内分泌刺激试验以进一步评估他的内分泌状况。这些检查显示对促甲状腺激素和甲状旁腺激素有抵抗,但促肾上腺皮质激素、生长激素和皮质醇分泌正常。埃尔斯沃思 - 霍华德试验导致尿中环磷酸腺苷排泄正常。这种反应与Ia型假性甲状旁腺功能减退症不同。总之,鼻子上翘、大多数(如果不是全部)指骨的骨骺呈锥形以及甲状旁腺激素抵抗且尿中环磷酸腺苷反应正常这一系列表现可能足以实现肢端发育不全的临床诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/514443a30015/cpe-26-177-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/241231a97e2a/cpe-26-177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/43557c68ef53/cpe-26-177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/965e65c0ef4e/cpe-26-177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/514443a30015/cpe-26-177-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/241231a97e2a/cpe-26-177-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/43557c68ef53/cpe-26-177-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/965e65c0ef4e/cpe-26-177-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/097c/5537214/514443a30015/cpe-26-177-g004.jpg

相似文献

1
Endocrinological and phenotype evaluation in a patient with acrodysostosis.一名肢端发育不全患者的内分泌学及表型评估
Clin Pediatr Endocrinol. 2017;26(3):177-182. doi: 10.1297/cpe.26.177. Epub 2017 Jul 27.
2
PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.PRKAR1A 突变影响肢端发育异常伴激素抵抗患者的 cAMP 介导的 G 蛋白偶联受体信号转导。
J Clin Endocrinol Metab. 2012 Sep;97(9):E1808-13. doi: 10.1210/jc.2012-1369. Epub 2012 Jun 20.
3
Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodysostosis to acroscyphodysplasia.扩展 PDE4D/PRKAR1A 变异的表型谱:从acrodyostosis 到 acroscyphodysplasia。
Eur J Hum Genet. 2018 Nov;26(11):1611-1622. doi: 10.1038/s41431-018-0135-1. Epub 2018 Jul 13.
4
PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.PRKAR1A 和 PDE4D 突变导致肢端骨发育不全,但有或没有 GPCR 信号激素抵抗的两种不同综合征。
J Clin Endocrinol Metab. 2012 Dec;97(12):E2328-38. doi: 10.1210/jc.2012-2326. Epub 2012 Oct 5.
5
[Genes in the cAMP pathway causing skeletal dysplasia with or without hormonal resistance].[导致伴有或不伴有激素抵抗的骨骼发育异常的环磷酸腺苷(cAMP)信号通路中的基因]
Biol Aujourdhui. 2016;210(3):167-170. doi: 10.1051/jbio/2016018. Epub 2016 Nov 4.
6
Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis.外显子组测序发现 PDE4D 突变是肢端发育异常的另一个原因。
Am J Hum Genet. 2012 Apr 6;90(4):740-5. doi: 10.1016/j.ajhg.2012.03.003. Epub 2012 Mar 29.
7
Acrodysostosis syndromes.肢端发育不全综合征
Bonekey Rep. 2012 Nov 21;1:225. doi: 10.1038/bonekey.2012.225.
8
Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.环磷酸腺苷磷酸二酯酶-4D(PDE4D)和蛋白激酶A(PKA)的杂合突变为肢端发育不全的分子病理学提供了新见解。
Cell Signal. 2014 Nov;26(11):2446-59. doi: 10.1016/j.cellsig.2014.07.025. Epub 2014 Jul 24.
9
Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis.敲入抑制环磷酸腺苷依赖性蛋白激酶A激活的PRKAR1A复发性R368X突变:1型肢端发育不全模型。
J Bone Miner Res. 2017 Feb;32(2):333-346. doi: 10.1002/jbmr.2987. Epub 2016 Oct 24.
10
Novel mutations of the PRKAR1A gene in patients with acrodysostosis.肢端肥大性骨发育不良患者的 PRKAR1A 基因突变。
Clin Genet. 2013 Dec;84(6):531-8. doi: 10.1111/cge.12106. Epub 2013 Feb 21.

引用本文的文献

1
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.肢端肥大症患者生长激素治疗的生长模式和结果。
J Endocrinol Invest. 2023 Aug;46(8):1673-1684. doi: 10.1007/s40618-023-02026-2. Epub 2023 Feb 7.
2
Acrodysostosis and pseudohypoparathyroidism (PHP): adaptation of Japanese patients with a newly proposed classification and expanding the phenotypic spectrum of variants.肢端骨发育不全与假性甲状旁腺功能减退症(PHP):日本患者对新提出的分类方法的适应性及变异型表型谱的扩展
Endocr Connect. 2022 Sep 22;11(10). doi: 10.1530/EC-22-0151. Print 2022 Oct 1.
3
A patient with extensive cerebral calcification due to pseudohypoparathyroidism: a case report.

本文引用的文献

1
Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.在意大利一个大型的临床诊断为阿尔布莱特遗传性骨营养不良症和/或假性甲状旁腺功能减退症的患者系列中筛选 PRKAR1A 和 PDE4D。
J Bone Miner Res. 2016 Jun;31(6):1215-24. doi: 10.1002/jbmr.2785. Epub 2016 Feb 9.
2
Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.小于胎龄儿(SGA)的患病率以及3岁时符合生长激素治疗条件的SGA出生儿童的身材矮小情况:基于人群的研究。
Pediatr Int. 2016 May;58(5):372-6. doi: 10.1111/ped.12859. Epub 2016 Feb 19.
3
一位患有假性甲状旁腺功能减退症所致广泛脑钙化的患者:病例报告。
BMC Endocr Disord. 2019 Dec 19;19(1):142. doi: 10.1186/s12902-019-0475-z.
Longitudinal growth of the short bones of the hand in a girl with pseudohypoparathyroidism type ia.
一名患有Ia型假性甲状旁腺功能减退症女孩手部短骨的纵向生长情况。
Clin Pediatr Endocrinol. 2007;16(1):23-9. doi: 10.1297/cpe.16.23. Epub 2007 Feb 7.
4
Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development.父源 GNAS 突变导致严重的宫内生长受限(IUGR),并为 XLαs 在胎儿发育中的作用提供了证据。
J Clin Endocrinol Metab. 2013 Sep;98(9):E1549-56. doi: 10.1210/jc.2013-1667. Epub 2013 Jul 24.
5
Novel mutations of the PRKAR1A gene in patients with acrodysostosis.肢端肥大性骨发育不良患者的 PRKAR1A 基因突变。
Clin Genet. 2013 Dec;84(6):531-8. doi: 10.1111/cge.12106. Epub 2013 Feb 21.
6
PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.PRKAR1A 和 PDE4D 突变导致肢端骨发育不全,但有或没有 GPCR 信号激素抵抗的两种不同综合征。
J Clin Endocrinol Metab. 2012 Dec;97(12):E2328-38. doi: 10.1210/jc.2012-2326. Epub 2012 Oct 5.
7
PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.PRKAR1A 突变影响肢端发育异常伴激素抵抗患者的 cAMP 介导的 G 蛋白偶联受体信号转导。
J Clin Endocrinol Metab. 2012 Sep;97(9):E1808-13. doi: 10.1210/jc.2012-1369. Epub 2012 Jun 20.
8
Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis.外显子组测序发现 PDE4D 突变是肢端发育异常的另一个原因。
Am J Hum Genet. 2012 Apr 6;90(4):740-5. doi: 10.1016/j.ajhg.2012.03.003. Epub 2012 Mar 29.
9
Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.肢端肥大症性骨发育不良伴激素抵抗中反复出现的 PRKAR1A 突变。
N Engl J Med. 2011 Jun 9;364(23):2218-26. doi: 10.1056/NEJMoa1012717.
10
Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society.小于胎龄儿从出生到成年期的管理:国际儿科内分泌学会和生长激素研究学会的共识声明
J Clin Endocrinol Metab. 2007 Mar;92(3):804-10. doi: 10.1210/jc.2006-2017. Epub 2007 Jan 2.